PRESS INFORMATION
Heading: 1st half 2018 results Nanterre, September 5, 2018 (after trading)
8.5% operating profit in the 1st half 2018
Accounts at June 30 (audited in € millions) | H1 2017 | 2017 | H1 2018 |
Revenues (*) | 245 | 485 | 243.1 |
Business operating profit (**) | 21.7 (8.9%) | 46.4 (9.6%) | 21.3 (8.8%) |
Operating profit | 21.1 (8.6%) | 44.9 (9.3%) | 20.6 (8.5%) |
Net financial income | 1.8 | 2.9 | 0.7 |
Tax on earnings | (7.7) | (16.2) | (7.5) |
Net profit after tax | 15.2 (6.2%) | 31.6 (6.5%) | 13.8 (5.7%) |
of which, group share | 13 | 27.3 | 12.1 |
Staff at end of period | 5,024 | 5,028 | 5,123 |
(*) applied since January 1, 2018, the effect of IFRS 15 is to decrease Group revenues approximately €9 million in 2017 and in 2018, without obviously an impact on operating profit. Revenues in the 1st half of 2017 restated for IFRS 15 would have been €239.2 million instead of the €245 million published.
(**) before cost of free shares
Achievements
On an identical scope and accounting method (IFRS 15) basis, the business activity grew 5.1% over the first six months of FY2018.
The operating profit for the half-year totaled 8.5% of revenues (8.6% in the first half of 2017).
Over a one-year period, cash flow (excluding financial debt) increased €11.6 million. At June 30, 2018, it stood at €148.3 million.
Outlook
For the entire 2018 fiscal year and on a like-for-like basis, Neurones maintains its forecast of more than €490 million in revenues (IFRS 15) and an operating profit of approximately 9% of revenues.
About Neurones
With over 5,100 employees, the Neurones group specializes in Consulting (Management, Organization and Digital) and IT Services (Infrastructures and Applications). It supports its clients in their digital transformation and information system outsourcing projects.
Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values
Press Relations: Florence Gillier Communication Sabine GROSDIDIER +33 1 41 18 85 55 sabineg@fgcom.fr | Neurones Matthieu VAUTIER +33 1 41 37 41 37 rp@neurones.net | Investor Relations: Neurones Paul-César BONNEL +33 1 41 37 41 37 investisseurs@neurones.net |
Attachment